Semaglutide Aids NASH Relief Via NonWeightLoss Actions
Semaglutide Shows Promise in Improving Liver Health in MASH Patients Exciting new data from the ESSENCE trial reveals that semaglutide
Continue ReadingJune 12, 2026
Semaglutide Shows Promise in Improving Liver Health in MASH Patients Exciting new data from the ESSENCE trial reveals that semaglutide
Continue ReadingUnveiling Immune Dysfunction in Liver Cirrhosis: A New Study Liver cirrhosis, a chronic liver disease, involves progressive scarring and impaired
Continue ReadingChina Targets Hepatitis Elimination in Newborns by 2030 China has launched an ambitious action plan to bolster newborn vaccination efforts
Continue ReadingGut Bacteria Molecule Shows Promise in Reversing Liver Damage Exciting new research from UC Davis Health reveals that a naturally
Continue ReadingPakistan and WHO Join Forces to Intensify Hepatitis C Eradication Efforts Pakistan and the World Health Organization (WHO) have committed
Continue ReadingAnjum Aqeel Khan Urges Public to Take Hepatitis Seriously Member of the National Assembly (MNA) Anjum Aqeel Khan is calling
Continue ReadingEarly Diagnosis of Alagille Syndrome in Infants Researchers suggest that identifying specific facial characteristics alongside heart complications can significantly enhance
Continue ReadingPrimary Biliary Cholangitis (PBC) Prevalence in Rural U.S. A recent study suggests that Primary Biliary Cholangitis (PBC) might be more
Continue ReadingThe Importance of Longitudinal Studies in Managing MASLD Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern, and
Continue ReadingRaising Awareness of Primary Biliary Cholangitis Through Art Gilead Sciences is employing a unique strategy to increase understanding and recognition
Continue Reading